Upper-arm aerobic exercise for arterial stiffness in women treated for breast cancer.
Official title: The Effect of Upper Extremity Aerobic Exercise Training on Arterial Stiffness in Individuals With Breast Cancer
Run by Hacettepe University · NCT07070778 · Data updated 2026-11-12
This trial will test whether an upper-extremity aerobic exercise program can reduce arterial stiffness in women aged 40–69 who are at least 15 months after breast cancer surgery and are currently physically inactive.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 69 Years |
| Sex | Women only |
| Enrollment | 18 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Ankara, State) |
| Status | Recruiting |
| Started | July 8, 2025 |
| Main results expected | November 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | December 29, 2025 |
| Trial ID | NCT07070778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women 40–69 years old who are at least 15 months post–breast cancer surgery, physically inactive, with LVEF >50% and no significant coronary or carotid disease.
✕Probably not a fit
Patients with active infections, bilateral breast cancer, significant cardiac, hepatic, renal, neurological, or musculoskeletal impairments affecting the arm are unlikely to benefit or will be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls women after breast cancer surgery to measure arterial stiffness before and after a program of upper-extremity aerobic exercise, examining both acute and chronic responses. Participants must have preserved cardiac function (LVEF >50%) and no significant coronary or carotid disease; those with active infection, bilateral disease, or major neurologic/musculoskeletal limitations are excluded. The intervention involves structured arm aerobic training sessions delivered onsite at Hacettepe University, with vascular measurements taken at baseline and after the training period. Results aim to clarify whether targeted arm exercise improves arterial stiffness and arm function in breast cancer survivors.
Why it matters
Potential benefit: If successful, the exercise program could reduce arterial stiffness and improve arm function and cardiovascular risk profiles for breast cancer survivors.
How similar studies have gone: Small studies have shown aerobic exercise can improve function after breast cancer and reduce arterial stiffness in other groups, but the effect of upper‑extremity aerobic training on arterial stiffness specifically in breast cancer survivors is not well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * To be between the ages of 40-69, * Baseline left ventricular ejection fraction (LVEF) \>50%, * Absence of coronary artery disease and haemodynamically significant valvular heart disease, * Absence of carotid atherosclerotic plaques, * Volunteering to participate in the research, * At least 15 months after breast cancer surgery, * No problems in reading and/or understanding the scales and being able to co-operate with the tests. * Physically inactive (60 minutes of structured exercise per week \<). Exclusion Criteria: * Presence of active infection, * Presence of bilateral breast cancer, * History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery, * Having a neurological disease or other clinical diagnosis that may affect cognitive status, * Left ventricular dysfunction and severe liver and kidney dysfunction before starting chemotherapy * Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease. * Presence of unstable hypertension or diabetes mellitus.
Where it's running
-
Hacettepe University
Ankara, State, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ebru Calik Kutukcu, PhD
- Email: ebru.calik@hacettepe.edu.tr
- Phone: +903123051576
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dapagliflozin to prevent chemotherapy-related heart damage in breast cancer
We will test if taking dapagliflozin 10 mg daily prevents heart and blood-vessel damage in adult women receiving anthracycline chemotherapy for breast cancer.
-
Combined upper-body resistance and aerobic exercise program for people treated for breast cancer
This program will test whether a combined upper-body resistance and aerobic exercise routine helps people at least 15 months after breast cancer surgery improve arm function, strength, and symptoms.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.